
Opinion|Videos|July 31, 2024
The Heterogeneity of Prostate Cancer
Experts on prostate cancer discuss the heterogeneity of the disease and the rationale for using medications with different mechanisms of action, including androgen deprivation therapy.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Testosterone deficiency: FAQs from the AUA guideline
2
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
3
From hype to practice: Urologists assess AI's real impact
4
Published BOND-003 data show durable responses with cretostimogene in NMIBC
5














